Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theranostics

Showing results (251-260 of 5,522) with videos related to

Pageof 553
Sort By:
Theranostics|April 14, 2025
EphA2-targeted alpha-particle theranostics for enhancing PDAC treatmentAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Theranostics|April 14, 2025
GLSP mitigates vascular aging by promoting Sirt7-mediated Keap1 deacetylation and Keap1-Nrf2 dissociationYanfei Cheng, Guobin Zheng, Heming Huang, et al.
Theranostics|April 14, 2025
Injectable cellular vesicle-based bone meal for inflammatory bone defect repair through restoring immune homeostasisYu-Yue Zhao, Qian-Fang Meng, Hao Cui, et al.
Theranostics|April 14, 2025
DNA nanorobot for mitochondria-targeted microRNAs detection and tailored regulationPing Huang, Xiaoqi Tang, Shuang Zhao, et al.
Theranostics|June 16, 2025
Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategiesYingshuai Fang, Wenming Cui, Yabing Yang, et al.
Theranostics|June 16, 2025
Boosting mRNA cancer vaccine efficacy via targeting <i>Irg1</i> on macrophages in lymph nodesWenwen Wei, Xiao Yang, Yeshan Chen, et al.
Theranostics|June 16, 2025
Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancerXiaojuan Yang, Jiang Zhu, Xue Tao, et al.
Theranostics|June 16, 2025
SUMOylation of SARS-CoV-2 spike protein is a key target for broad-spectrum antiviral therapyXinyu Wang, Gaowei Hu, Yupeng Shao, et al.
Theranostics|June 16, 2025
IFN-I-mediated neutropoiesis bias drives neutrophil priming and inflammatory comorbiditiesYuman Li, Yiming Chen, Chenyu Deng, et al.
Theranostics|May 14, 2025
Optimizing theranostics chatbots with context-augmented large language modelsPia Koller, Christoph Clement, Albert van Eijk, et al.
Pageof 553

Showing results (251-260 of 5,522) with videos related to

Sort By:
Pageof 553
Theranostics|April 14, 2025
EphA2-targeted alpha-particle theranostics for enhancing PDAC treatmentAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Theranostics|April 14, 2025
GLSP mitigates vascular aging by promoting Sirt7-mediated Keap1 deacetylation and Keap1-Nrf2 dissociationYanfei Cheng, Guobin Zheng, Heming Huang, et al.
Theranostics|April 14, 2025
Injectable cellular vesicle-based bone meal for inflammatory bone defect repair through restoring immune homeostasisYu-Yue Zhao, Qian-Fang Meng, Hao Cui, et al.
Theranostics|April 14, 2025
DNA nanorobot for mitochondria-targeted microRNAs detection and tailored regulationPing Huang, Xiaoqi Tang, Shuang Zhao, et al.
Theranostics|June 16, 2025
Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategiesYingshuai Fang, Wenming Cui, Yabing Yang, et al.
Theranostics|June 16, 2025
Boosting mRNA cancer vaccine efficacy via targeting <i>Irg1</i> on macrophages in lymph nodesWenwen Wei, Xiao Yang, Yeshan Chen, et al.
Theranostics|June 16, 2025
Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancerXiaojuan Yang, Jiang Zhu, Xue Tao, et al.
Theranostics|June 16, 2025
SUMOylation of SARS-CoV-2 spike protein is a key target for broad-spectrum antiviral therapyXinyu Wang, Gaowei Hu, Yupeng Shao, et al.
Theranostics|June 16, 2025
IFN-I-mediated neutropoiesis bias drives neutrophil priming and inflammatory comorbiditiesYuman Li, Yiming Chen, Chenyu Deng, et al.
Theranostics|May 14, 2025
Optimizing theranostics chatbots with context-augmented large language modelsPia Koller, Christoph Clement, Albert van Eijk, et al.
Pageof 553